Placental growth factor testing for suspected pre-eclampsia

Affiliations

¹ Department of Obstetrics and Gynaecology, Faculty of Medicine, Université Laval, Quebec City, QC G1V 4G2, Canada. Electronic address: emmanuel.bujold@crchudequebec.ulaval.ca.
² Department of Obstetrics and Gynaecology, Faculty of Medicine, Université Laval, Quebec City, QC G1V 4G2, Canada.
³ Department of Obstetrics & Gynaecology, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada.

Free article

Comment

Emmanuel Bujold et al. Lancet. 2019.

Free article

. 2019 May 4;393(10183):1775-1776.

doi: 10.1016/S0140-6736(19)30958-4.

¹ Department of Obstetrics and Gynaecology, Faculty of Medicine, Université Laval, Quebec City, QC G1V 4G2, Canada. Electronic address: emmanuel.bujold@crchudequebec.ulaval.ca.
² Department of Obstetrics and Gynaecology, Faculty of Medicine, Université Laval, Quebec City, QC G1V 4G2, Canada.
³ Department of Obstetrics & Gynaecology, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada.

No abstract available

Comment in

A top priority in pre-eclampsia research: development of a reliable and inexpensive urinary screening test.
Scioscia M, Dekker GA, Chaouat G, Dawonauth L, Dechend R, Goldman-Wohl D, Gumilar E, Karumanchi SA, Kell DB, Rademacher TW, Robertson S, Saito S, Scherjon S, Staff AC, Vatish M, Robillard PY. Scioscia M, et al. Lancet Glob Health. 2019 Oct;7(10):e1312-e1313. doi: 10.1016/S2214-109X(19)30319-5. Lancet Glob Health. 2019. PMID: 31537353 No abstract available.

Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial.
Duhig KE, Myers J, Seed PT, Sparkes J, Lowe J, Hunter RM, Shennan AH, Chappell LC; PARROT trial group. Duhig KE, et al. Lancet. 2019 May 4;393(10183):1807-1818. doi: 10.1016/S0140-6736(18)33212-4. Epub 2019 Apr 1. Lancet. 2019. PMID: 30948284 Free PMC article. Clinical Trial.